Annals of the American Thoracic Society

Collaborative Primary Palliative Care in Serious Illness: A Pragmatic Path Forward.  20:358-360. 2023

Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.  20:206-214. 2023

Flow-Volume Curve Patterns in Radiologic Expiratory Central Airway Collapse. 2023

Access to Pulmonary Rehabilitation Among Medicare Beneficiaries with COPD. 2022

Acute Exacerbations Are Associated with Progression of Emphysema.  19:2108-2111. 2022

Pulmonary Function Trajectories in People with HIV: Analysis of the Pittsburgh HIV Lung Cohort.  19:2013-2020. 2022

Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.  19:1642-1649. 2022

Telemedicine for Patients with Chronic Pulmonary Diseases in the COVID-19 Era and Beyond.  19:1448-1450. 2022

Pooled Cohort Probability Score for Subclinical Airflow Obstruction.  19:1294-1304. 2022

Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease.  19:1093-1095. 2022

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis An Analysis of the IPF-PRO Registry.  19:981-990. 2022

Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical Trial.  19:685-687. 2022

Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease.  19:171-178. 2022

Video Telehealth Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Is Associated with Clinical Improvement Similar to Center-based Pulmonary Rehabilitation.  19:332-335. 2022

Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts.  19:143-146. 2022

Expanding Implementation of Tele-Pulmonary Rehabilitation: The New Frontier.  19:3-4. 2022

Chronotropic index and acute exacerbations of chronic obstructive pulmonary disease a secondary analysis of block Copd.  18:1795-1802. 2021

Defining resilience to smoking-related lung disease a modified delphi approach from Spiromics.  18:1822-1831. 2021

avorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.  18:1588-1592. 2021

Portable, consumer-grade pulse oximeters are accurate for home and medical use: Implications for their use in patients with COVID-19.  18:1260-1261. 2021

The long and the short of it: Is "long covid" more than slow resolution of the acute disease?.  18:948-950. 2021

Risk of exacerbation and pneumonia with single-inhaler triple versus dual therapy in IMPACT.  18:788-798. 2021

The ARREST Pneumonia clinical trial: Rationale and design.  18:698-708. 2021

Niranjan SJ, Opoku-Agyeman W, Carroll NW, Dorsey A, Tipre M, Baskin ML, Dransfield MT. Distribution and Geographic Accessibility of Lung Cancer Screening Centers in the US. Ann Am Thorac Soc. 2021 Mar 30. doi: 10.1513/AnnalsATS.202010-1313RL. Epub ahead of print. PMID: 33784236. 2021

Social inequities and cystic fibrosis outcomes: we can do better.  18:215-217. 2021

Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR A Clinical Trial.  18:75-83. 2021

Recipient Age Impacts Long-Term Survival in Adult Subjects with Cystic Fibrosis after Lung Transplantation.  18:44-50. 2021

The pulmonary fibrosis foundation patient registry: Rationale, design, and methods.  17:1620-1628. 2020

Upper airway stimulation versus untreated comparators in positive airway pressure treatment-refractory obstructive sleep apnea.  17:1610-1619. 2020

Risk Factors for Cardiovascular Collapse during Tracheal Intubation of Critically III Adults.  17:1021-1024. 2020

Both Duration and Pack-Years of Tobacco Smoking Should Be Used for Clinical Practice and Research.  17:804-806. 2020

Effect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trial.  17:829-838. 2020

Associations between patient-reported outcomes and death or lung transplant in idiopathic pulmonary fibrosis data from the idiopathic pulmonary fibrosis prospective outcomes registry.  17:699-705. 2020

Changes in airway microbiome and inflammation with ivacaftor treatment in patients with cystic fibrosis and the G551D mutation.  17:212-220. 2020

A formative evaluation of patient and family caregiver perspectives on early palliative care in chronic obstructive pulmonary disease across disease severity.  16:1024-1033. 2019

Emulating a novel clinical trial using existing observational data predicting results of the PREVENT study.  16:998-1007. 2019

Imaging small airway disease: Probabilities and possibilities.  16:975-977. 2019

The peak index: Spirometry metric for airflow obstruction severity and heterogeneity.  16:982-989. 2019

Physical function trajectories in survivors of acute respiratory failure.  16:471-477. 2019

Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease results from the SPIROMICS bronchoscopy substudy.  16:439-446. 2019

Alignment of inhaled chronic obstructive pulmonary disease therapies with published strategies :analysis of the Global Initiative for Chronic Obstructive Lung Disease recommendations in SpiroMics.  16:200-208. 2019

Reducing chronic obstructive pulmonary disease hospital readmissions: An official American Thoracic Society workshop report.  16:161-170. 2019

Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study.  16:150-153. 2019

Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease.  16:826-835. 2019

How to detect tobacco-related vasculopathy: Are we there yet?.  16:674-675. 2019

It’s time to rehabilitate pulmonary rehabilitation.  16:55-57. 2019

Occupational exposures and computed tomographic imaging characteristics in the SpiromICS cohort.  15:1411-1419. 2018

Functional anatomic imaging of the airway surface.  15:S177-S183. 2018

Risk factors for and prediction of hypoxemia during tracheal intubation of Critically Ill Adults.  15:1320-1327. 2018

Searching for the source of the leak: PIE and the macklin effect.  15:1354-1356. 2018

Rural residence and chronic obstructive pulmonary disease exacerbations: Analysis of the SPIROMICS cohort.  15:808-815. 2018

Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS..  15:710-717. 2018

B-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk an observational substudy of SUMMIT.  15:608-614. 2018

Home-based physical activity coaching, physical activity, and health care utilization in chronic obstructive pulmonary disease chronic obstructive pulmonary disease self-management activation research trial secondary outcomes.  15:470-478. 2018

Paratracheal paraseptal emphysema and expiratory central airway collapse in smokers.  15:479-484. 2018

Recent advances in computed tomography imaging in chronic obstructive pulmonary disease.  15:281-289. 2018

Diagnosis of chronic obstructive pulmonary disease: Breathing new life into an old debate.  15:163-165. 2018

Reply: We did this, and the patient improved: True, true, and unrelated?.  15:269. 2018

The "Obesity paradox" in chronic obstructive pulmonary disease: Can it be resolved?.  15:158-159. 2018

The long-term oxygen treatment trial for chronic obstructive pulmonary disease: Rationale, design, and lessons learned.  15:89-101. 2018

Handgrip strength in chronic obstructive pulmonary disease associations with acute exacerbations and body composition.  14:1638-1645. 2017

Mitochondrial dysfunction in pulmonary fibrosis.  14:S383-S388. 2017

Progressive dyspnea and back pain after complicated pneumonia.  14:1714-1717. 2017

Clinical risk factors and prognostic model for primary graft dysfunction after lung transplantation in patients with pulmonary hypertension.  14:1514-1522. 2017

Going with the flow: Saddle pulmonary embolism complicated by severe hypoxemia without shock.  14:1479-1484. 2017

Measures of frailty in chronic lung diseases.  14:1266-1267. 2017

An official American Thoracic Society Workshop Report: Chemical inhalational disasters biology of lung injury, development of novel therapeutics, and medical preparedness.  14:1060-1072. 2017

Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes an analysis of the subpopulations and intermediate outcome measures in COPD Study cohort.  14:636-642. 2017

Results of a Medicare Bundled Payments for care Improvement initiative for chronic obstructive pulmonary disease readmissions.  14:643-648. 2017

Liberation from mechanical ventilation in critically Ill adults: An official ATS/ACCP clinical practice guideline.  14:441-443. 2017

Abnormal glucose metabolism and high-energy expenditure in idiopathic pulmonary arterial hypertension.  14:190-199. 2017

Characterization of prostacyclin-associated leg pain in patients with pulmonary arterial hypertension.  14:206-212. 2017

Lumacaftor/ivacaftor treatment of patients with cystic fibrosis heterozygous for F508del-CFTR.  14:213-219. 2017

Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden.  14:26-32. 2017

Constrictive bronchiolitis in cystic fibrosis adolescents with refractory pulmonary decline.  13:2174-2183. 2016

Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease.  13:1016-1025. 2016

A lifestyle physical activity intervention for patients with chronic obstructive pulmonary disease a randomized controlled trial.  13:617-626. 2016

Vitamin D concentrations and obstructive sleep apnea in a multicenter cohort of older males.  13:712-718. 2016

Neutrophil fates in bronchiectasis and alpha-1 antitrypsin deficiency.  13:S123-S129. 2016

Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in Chronic bronchitis.  13:S169-S176. 2016

Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease.  13:197-203. 2016

Increased costs of the asthma-chronic obstructive pulmonary disease overlap syndrome one syndrome for the price of two?.  13:158-159. 2016

Attenuation of MIR-17∼92 cluster in bronchopulmonary dysplasia.  12:1506-1513. 2015

Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction.  12:1105-1106. 2015

Multicenter observational study on factors and outcomes associated with various methicillin-resistant Staphylococcus aureus types in children with cystic fibrosis.  12:864-871. 2015

Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk.  12:648-656. 2015

Hypoxia-Inducible Factor–Dependent CXCR4/SDF1 Signaling Promotes Alveolar Type II Cell Spreading and the Resolution of Epithelial Permeability after Lung Injury.  12:s72-s73. 2015

Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.  12:27-34. 2015

Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.  11:1411-1418. 2014

Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.  11:1387-1394. 2014

The feasibility of lung transplantation in HIV-seropositive patients.  11:945-950. 2014

Domain-specific self-efficacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease.  11:310-315. 2014

FEV1/FEV6to diagnose airflow obstruction: Comparisons with computed tomography and morbidity indices.  11:335-341. 2014

Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.  11:685-694. 2014

Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease: A cross-sectional study.  11:326-334. 2014

Adult-onset asthma becomes the dominant phenotype among women by age 40 years: The longitudinal CARDIA study.  10:188-197. 2013

Exposing animals to oxidant gases: Nose only vs. whole body.  7:264-268. 2010

Mechanisms and modification of chlorine-induced lung injury in animals.  7:278-283. 2010

Potential for chlorine gas-induced injury in the extrapulmonary vasculature.  7:290-293. 2010

Understanding and treating chlorine-induced lung injury.  7:253. 2010

An official American Thoracic Society Workshop Report: Tobacco control initiatives within the American Thoracic Society.  7:1-7. 2010

Pharmacologic therapy: Novel approaches for chronic obstructive pulmonary disease.  4:543-548. 2007

Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.  4:387-398. 2007

Altered T-cell phenotypes in chronic obstructive pulmonary disease.  3:487-488. 2006

Regulation of Na+ channels in lung alveolar type II epithelial cells..  1:10-16. 2004